An activator of protein kinase C (phorbol-12-myristate-13-acetate) augments 2-chloroadenosine-elicited accumulation of cyclic AMP in guinea pig cerebral cortical particulate preparations  by Hollingsworth, Elizabeth B. et al.
Volume 184, number 2 FEBS 2571 May 1985 
An activator of protein kinase C 
(phorbol- 12-myristate- 13-acetate) augments 
2-chloroadenosine-elicited accumulation of cyclic AMP in 
guinea pig cerebral cortical particulate preparations 
Elizabeth B. Hollingsworth, Edward B. Sears and John W. Daly 
Laboratory of Bioorganic Chemistry, Bldg 4, Room 212, National Institute of Arthritis, Diabetes, and Digestive and Kidney 
Diseases, National Institutes of Health, Bethesda, IUD 20205, USA 
Received 14 March 1985; revised version received 5 April 1985 
Norepinephrine and histamine markedly augment accumulations of cyclic AMP elicited by 2-chloroadeno- 
sine in a guinea pig cerebral cortical vesicular preparation. In addition, these biogenic amines stimulate 
phosphatidylinositol turnover. Phosphatidylinositol turnover is associated with mobilization of internal cal- 
cium and with stimulation of protein kinase C. Phorbol-lZmyristate-13-acetate (PMA), a known activator 
of protein kinase C, has no effect on cyclic AMP levels alone, but in a concentration-dependent manner 
enhances accumulations of cyclic AMP elicited by 2-chloroadenosine. PMA, like norepinephrine, also en- 
hances accumulations of cyclic AMP elicited by histamine. PMA has no effect on the synergistic accumula- 
tions of cyclic AMP elicited by combinations of amines and 2-chloroadenosine. PMA also augments accu- 
mulations of cyclic AMP elicited by forskolin. The results suggest hat activation of,phosphatidylinositol 
turnover by biogenic amines may lead via stimulation of protein kinase C to enhanced responsiveness of 
cyclic AMP-generating systems. 
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1. INTRODUCTION 
Biogenic amines, such as norepinephrine and 
histamine, can markedly augment accumulations 
of cyclic AMP elicited by adenosines in rodent 
brain slices and particulate preparations ([I ,2] and 
references therein). The mechanism(s) involved in 
these calcium-dependent synergisms [3] is un- 
known. However, the ai-adrenergic and Hi-his- 
taminergic receptors that subserve synergistic in- 
creases in cyclic AMP in brain slices also stimulate 
phosphatidylinositol turnover in brain slices [4-61. 
Receptor-mediated hydrolysis of phosphatidylino- 
sitol forms both inositol phosphates and diacylgly- 
cerols [7]. The inositol phosphates stimulate re- 
lease of calcium from intracellular stores, while 
diacylglycerol activates protein kinase C. Thus, 
either calcium release or activation of protein 
kinase C, initiated by ai-adrenergic or Hi-histami- 
nergic receptors, might be involved in synergistic 
cyclic AMP accumulations in brain preparations. 
Phorbol-12-myristate-13-acetate (PMA), a natur- 
ally occurring activator of protein kinase C [S], has 
now been found to augment 2-chloroadenosine-eli- 
cited accumulations of cyclic AMP in a particulate 
preparation from guinea pig cerebral cortex. 
2. MATERIALS AND METHODS 
2.1. Particulate preparations 
The brain particulate preparation [2,9,10] was 
obtained as follows: brains from two male guinea 
pigs (210-300 g) were excised after decapitation. 
Slices of cerebral cortical grey matter were homo- 
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genized in 7 ml Krebs-Henseleit (KRBS) buf- 
fer which contains 118.5 mM NaCl, 4.7 mM 
KCI, 1.2 mM MgSO4, 2.5 mM CaC12, 1.2 mM 
KH2P04, 24.9 mM NaHC03 and 20 mM glucose 
at pH 7.4 and pregassed with 95% OZ-5% COz. 
The homogenate was centrifuged at 2000 x g for 
10 min. The supernatant was discarded and the 
pellet resuspended in 20 ml KRBS buffer contain- 
ing 10 pg/ml adenosine deaminase. 
2.2. Cyciic AMP accumulation 
The resuspended particulate preparation was in- 
cubated in 10 ml KRBS buffer in the presence of 
0.3 FM [3H]adenine (100,&i) for 30 min, while 
being shaken gently and gassed with 95% OZ-5Yo 
COZ. After centrifugation at 1000 x g for 10 min 
and washing, the pellet (-50 mg protein) was 
resuspended in 50 ml KRBS buffer containing 
10 pg/ml adenosine deaminase. After incubation 
for 30 min, 1 ml aliquots were placed in scintilla- 
tion vials and incubated an additions 10 min. 
Agonists were added and after incubation at 37°C 
for 10 min, each suspension was transferred to a 
microfuge tube and centrifuged at 1000 x g for 5 s. 
After the supernatant was removed, the pellet was 
vortex-mixed with 1.2 ml of 6% trichloroacetic 
acid containing 230 pl of 1 mM cyclic AMP. Isola- 
tion of [3H]cyclic AMP was as described [l]. 
Results are expressed as percentage of total [3H]- 
adenine nucleotides present as [3H]cyclic AMP. 
The resuspended guinea pig cerebral cortical 
particulate preparations were incubated in 10 ml 
KRBS at 3’7OC for 30 min with 0.5 ,uM [‘H]inositol 
(0.85 pCi) with shaking and gassing with 95% 
02-5% COs. After centrifugation at 1000 X g for 
10 min and washing, the pellet (-50 mg protein) 
was resuspended in 50 ml KRBS buffer and 1 ml 
aliquots were incubated with various agents in the 
presence of 10 mM LiCl. The inositol phosphates, 
after removal of lipids with a chloroform : metha- 
nol mixture, were isolated by ion-exehange chro- 
matography essentially as described in [I 11. 
3. RESULTS 
The phorbol ester (PMA) has no effect on basal 
accumulation of cyclic AMP, but augments the 
2-~hloroadenosine response by 60% in a dose- 
340 
dependent manner with an apparent EC50 of about 
5 pM (fig. 1). This EGO is comparable to the EC50 
of 2 FM reported for the effects of PMA in parotid 
slices 1121, but is much higher than the concentra- 
tions required in cell-free systems to activate pro- 
tein kinase C [8]. PMA (10 PM) also augments the 
accumulation of cyclic AMP elicited by 2-chloro- 
adenosine by about 400/, in brain slices (not 
shown). PMA augments the accumulations of 
cyclic AMP elicited by another agonist, histamine, 
and by a direct activator of adenylate cyclase, fors- 
kolin (fig.2). Synergistic accumulations of cyclic 
AMP elicited by combinations of norepinephrine 
and 2-chloroadenosine, histamine and 2-chloro- 
adenosine, or norepinephrine and histamine are 
not further augmented by the presence of PMA 
(fig.2). 4-O-Methyl-PMA (10 yM), a phorbol ester 
that is inactive with respect o protein kinase C [S], 
has no effect on the 2-chloroadenosine-elicited ac- 
cumulation of cyclic AMP (not shown). 
Norepinephrine and histamine elicit significant 
accumulations of inositol phosphates in guinea pig 
cerebral cortical vesicular preparations: during 
60 min incubations of [3H]inositol-labeled pre- 
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Fig. 1. Accumuiations of radioactive cyclic AMP elicited 
by phorbol-12-myristate-13-acetate (PMA, 2 x lo-’ to 
2 x 10m4 M) alone (0) and in the presence of 2-chloro- 
adenosine (0) in [3H]adenine-labeled Krebs-Henseleit 
particulate preparations from guinea pig cerebral cortex. 
Incubations were for 10 min. Values are means f SE of 
a typical experiment performed in triplicate. Two other 
experiments gave simiiar results. 
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11 norepinephrine-response is mediated by au 
at-adrenergic receptor; the histamine-response by 
an ~l-his~a~~e~~ic receptor g 131. 
4. DISCUSSION 
Control NE I-IN Z-CiAdo FSK 2 t-c tAdo HN 
Biogenic amines augment the accumulations of 
cyclic AMP elicited by adenosine and adenosine 
analogs in brain preparations via i~tera~~on with 
rrr-adrenergic and HI-histaminergic receptors 
([ 1,2] and references therein). mr-Adrenergic and 
Hr-histaminergic receptors have no known direct 
effects on adenylate cyctase systems. Activation of 
at adrenergic and H 1 -~st~~ner~ic receptors does 
stimulate phosph~t~dy~~nosito~ breakdown in 
guinea pig cerebral cortical preparations as as- 
sessed in the presence of 10 mM Li’ (table 2; see 
also ]4-6,13]), and it appeared possible that the 
products of phosphat~dy~inosito~ urnover might 
be involved in s~erg~~~c a cum~iat~o~s of cyclic 
AMP in brain preparations. 
-5 + f 
NE NE PaAda 
Fig,Z. Accwmulations of radioactive cyclic AMP elicited 
by various agents in the presence (hatched bars) or 
absence (open bars) of phorbol- 1 Z-myristate- XJ-acetate 
(PMA) (IO ,&I) in ~3H]aden~~~~labeled Krebs-Wenseleit 
particnlate ~~~~rations from guinea pig cerebral cortex. 
Incubations were for IO min in the presence of I00~M 
norepinephrine (NE), or 100,&l histamine (Hrri), or 
100 pM 2-chloroadenosine (2ClAdo) or IO /rM fors- 
kolin (FSK) or combinations thereof. Values are means 
t SE of 2-4 experiments run in triplicate, Asterisk 
denotes a s~~~~f~cant greater stimulation by the agent in 
the presence of PMA @ < 0.05). 
Table 1 
Accumulation of radioactive ittositol phosphates in 
~~~]inos~tol-l~b~l~ Krebs Nensdeit particulate prepara- 
tions from guinea pig cerebral cortex 
Agent ]3H]Inositol 
phosphates 
f% of conttol) 
~ore~in~~~iu~ (0. I mM) 
Histamine (0%X mM) 
Carbamylcholine (2 mM) 
221 4 27 
I%* 4 
194 1?: I4 
Particulate preparations were labeled, incubated with 
agents for 60 min and assayed as described in section 2. 
Results are expressed as means f SE of a typicd 
experiment run iI5 tripEcaEe 
parations in the presence of 10 mM lithium, nor- 
epinephrine increases the accumulation of inositol 
phosphates by X&fold over basal values, whiIe 
histamine increase levels by I &fold (table 1). The 
S’t has been proposed that receptor-mediated 
breakdown of phosphatidylinositoX has the follow- 
ing sequelae: (1) calcium release from the en- 
d~p~~srnic reticulum through the action of inositof 
t~~p~osph~e~ (2) stimulation of protein kinase C 
through the action of the diacylglycerof ft], 
Diacylglycerol-elicited activation of protein kinase 
C can be mimicked by PMA [8]. Since PMA, like 
the biogenic amines, augments the accumulation 
of cyclic AMP elicited by 2-chloroadenosine, the 
data suggest hat activation of Al-adrener~c and 
H r -histaminergic receptors might augment cyclic 
AMP accumulation in guinea pig cerebral cortical 
preparations through stimulation of phosphatidyl- 
inositol turnover, thereby generating diacylglyce- 
t-o& which then activates protein kinase C. PMA 
does not further a~~rnent the synergistic responses, 
providing evidence supportive of the conclusion 
that the amines norepinephrine and histamine may 
act through the same pathway activated by PMA, 
namely protein kinase C. PMA also augments ao 
c~m~Iat~o~s of cyclic *AMP elicited by forskoi~~ 
(figL& The effect of activation of ml-adrenergic 
receptors or HI-histaminergic receptors on fors- 
kolin-responses has not been fully defined [14] e 
Further studies will. be needed to define the protein 
substrate involved in PMA-mediated augmenta- 
tion of cyclic ASP-accumulation in brain tissue- 
341 
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